ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
ReviR Therapeutics's investors include Sky9 Capital, CDH Investments, XtalPi, Shunwei Capital, 5Y Capital.
ReviR Therapeutics is headquartered in Brisbane, United States.
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
ReviR Therapeutics is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ReviR Therapeutics — Funding & Investors." VCBacked, April 21, 2026, https://www.vcbacked.co/company/revir-therapeutics. Accessed October 29, 2026.
VCBacked. (2026). ReviR Therapeutics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/revir-therapeutics
{{cite web |title=ReviR Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/revir-therapeutics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated